Eight drugs added to less insurance coverage have less coverage on 8 drugs

Published: 2012-09-12 06:59:00

Updated: 2012-09-12 06:59:00

The Health Insurance Review and Assessment Service said Monday that eight medicines, including Ilyang Pharmaceutical’s Supect, a newly developed drug for myelogenous leukemia and Hanmi Pharmaceutical’s Rispidone, will be added to a list of 1,332 drugs that are subject to less insurance coverage, when prescribed.

Based on the current Drug Utilization Review (DUR) system, the eight products ma...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.